Cardiovascular risk scores do not account for the effect of treatment: a review.
The use of risk-factor-modifying drugs-for example, statins-and disease-modifying medication-for example, platelet inhibitors-was not accounted for. In addition, none of the risk scores addressed the effect of treatment drop-ins-that is, treatment started during the study period. Ideally, a risk sco...
Saved in:
Main Authors: | Liew, S.M., Doust, J., Glasziou, P. |
---|---|
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/1826/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072200/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular risk score – review of its assessment methods and outcome
by: Shalihin, Mohd Shaiful Ehsan, et al.
Published: (2023) -
Framingham risk scores and anthropometric measurements in predicting cardiovascular risks among Malay men
by: Moy, Foong Ming, et al.
Published: (2008) -
Should identical CVD risks in young and old patients be managed identically? results from two models
by: Liew, S.M., et al.
Published: (2012) -
Growth hormone deficiency and cardiovascular risk.
by: Hew, F.L., et al.
Published: (1998) -
Health innovation in cardiovascular diseases
by: Liew, S.M., et al.
Published: (2013)